Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

Ma, Jianyi, Yee, Ann, Brewer, H. Bryan, Das, Saumya, Potter, Huntington·1994·Nature
DOI 10.1038/372092a0

Cited by (868)

Items 701–800 of 868

  1. Overexpression of the IGF-II/M6P Receptor in Mouse Fibroblast Cell Lines Differentially Alters Expression Profiles of Genes Involved in Alzheimer’s Disease-Related Pathology
    Yanlin Wang, Gopal Thinakaran, Satyabrata Kar · 2014 · PLoS ONE
  2. Blood-borne factors inhibit Alzheimer's β-amyloid fibril formation in vitro
    Kenjiro Ono, Moeko Noguchi‐Shinohara, Miharu Samuraki, Yasuko Matsumoto, Daisuke Yanase, Kazuo Iwasa, Hironobu Naiki, Masahito Yamada · 2006 · Experimental Neurology
  3. Alpha1 antichymotrypsin signal peptide polymorphism in sporadic Creutzfeldt–Jakob disease
    Mirella Salvatore, Angela Claudia Seeber, Benedetta Nacmias, Rosella P. Petraroli, Sandro Sorbi, Maurizio Pocchiari · 1997 · Neuroscience Letters
  4. Strategies to alter the progression of Alzheimer's disease
    Robert G. Siman · 1996 · Current Opinion in Biotechnology
  5. Purification of a novel serpin-like protein from bovine brain
    Masahiro Nishibori, Takashi Chikai, Masahiro Kawabata, Jun Ohta, TOSHIHIKO UBUKA, Kiyomi Saeki · 1995 · Neuroscience Research
  6. Apolipoprotein E4 genotype is not a risk factor for systemic AA amyloidosis or familial amyloid polyneuropathy
    Laurence B. Lovat, Susanne E. Booth, David Richmond Booth, Sheril Madhoo, Gösta Holmgren, Philip Nigel Hawkins, Anne K. Soutar, Mark B. Pepys · 1995 · Amyloid
  7. Novel Variations in β-Myosin Heavy-Chain Gene (β-MYH7) and Its Association in South Indian Women with Cardiomyopathies
    Deepa Selvi Rani, Pratibha Nallari, Calambur Narasimhan, Kumarasamy Thangaraj K · 2019 · Indian Journal of Cardiovascular Disease in Women
  8. Alzheimer Disease
    Dennis J. Selkoe · 2014 · Elsevier eBooks
  9. Neuropeptide Y receptor gene regulation in mouse adrenocortical Y-1 cells
    Gezhi Weng, Douglas L. Feinstein, Donald J. Reis, Claes Wahlestedt · 1996 · Regulatory Peptides
  10. Untitled work
    1999 · 10.1002/(sici)1096-8628(19991215)88:6
  11. Beta-amyloid protein-containing inclusions in skeletal muscle of apolipoprotein-E-deficient mice.
    T. A. Robertson, Nichole Dutton, Ralph Nigel Martins, Allen D. Roses, Byron A. Kakulas, J. M. Papadimitriou · 1997 · Europe PMC (PubMed Central)
  12. Novel Susceptibility Loci for Alzheimer's DXSisease
    Christiane Reitz · 2015 · Future Neurology
  13. Apolipoprotein E and Alzheimer’s Disease: State of the Field After Two Years
    Allen D. Roses, Warren J. Strittmatter, Ann M. Saunders, D. E. Schmechel, Margaret Ann Pericak‐Vance · 1996 · Springer eBooks
  14. Characterisation of Two Serine Protease Inhibitors Expressed in the Pituitary Gland
    Brennan Fell, Angela M. Smith, Rena M. Hill, Parmjeet K. PARMAR, Leigh C. Coates, Éva Mezey, Nigel P. Birch · 2002 · Archives of Physiology and Biochemistry
  15. Phosphodiesterase 4D Gene Modifies the Functional Network of Patients With Mild Cognitive Impairment and Alzheimer’s Disease
    Jie Xiang, Xin Wang, Yuan Gao, Ting Li, Rui Cao, Ting Yan, Yunxiao Ma, Yan Niu, Jiayue Xue, Bin Wang · 2020 · Frontiers in Genetics
  16. Relation between Apolipoprotein E in Alzheimer’s Disease and SARS-CoV-2 and their Treatment Strategy: A Review
    Anu Kunnath Ramachandran, Subham Das, Gurupur Gautham Shenoy, Jayesh Mudgal, Alex Joseph · 2022 · CNS & Neurological Disorders - Drug Targets
  17. Immunotherapy for Alzheimer‘s Disease
    Michael O Steinitz · 2009 · Immunotherapy
  18. Comprehensive expression analysis with cell-type-specific transcriptome in ALS-linked mutant SOD1 mice: Revisiting the active role of glial cells in disease
    Hirofumi Yamashita, Okiru Komine, Noriko Fujimori-Tonou, Koji Yamanaka · 2023 · Frontiers in Cellular Neuroscience
  19. Immunohistochemical Study on the Deposition of Apolipoprotein E in Cerebral and Islet Amyloidoses in Cynomolgus Monkeys (Macaca fascicularis).
    Shinichiro Nakamura, Wijit Kiatipattanasakul, Hiroyuki Nakayama, Fumiko Ono, Ippei Sakakibara, Yasuhiro Yoshikawa, Naoaki GOTO, Kunio Doi · 1996 · EXPERIMENTAL ANIMALS
  20. Interactions of Aβ with Endogenous Anti-Inflammatory Agents: A Basis for Chronic Neuroinflammation in Alzheimer's Disease
    Sabina M Janciauskiene, Yongxin Sun, H.T. Wright · 2002 · Neurobiology of Disease
  21. Genomics of immune molecules: early detection of cognitive decline and new therapeutic interventions
    Federico Licastro · 2002 · Expert Review of Neurotherapeutics
  22. Alzheimer’s disease and related dementias: prospects for treatment
    Michael J. Williams, Robert E. Davis · 1997 · Expert Opinion on Investigational Drugs
  23. Apolipoprotein E and Alzheimer’s disease
    Robert W. Mahley · 1995 · Developments in cardiovascular medicine
  24. Unraveling APOE4: The dual role in CNS and peripheral inflammation in Alzheimer's disease
    Xiaohan Li, Zekun Li, Hua Chen, Hongmin Guo, Yihao Ge, Fang Dong, Fan Zhang, Feng Zhang · 2025 · International Immunopharmacology
  25. Amyloid β 1–43 Accumulates in the Lens Epithelium of Cortical Opacification in Japanese Patients
    Noriaki Nagai, Yu Mano, Hiroko Otake, Teppei Shibata, Eri Kubo, Hiroshi Sasaki · 2017 · Investigative Ophthalmology & Visual Science
  26. No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans
    Ki Woong Kim, J.H. Jhoo, K.U. Lee, D.Y. Lee, J.H. Lee, J.Y. Youn, Bok Jik Lee, S.H. Han, Jong Inn Woo · 2000 · American Journal of Medical Genetics
  27. Adrenoceptor-stimulated inflammatory response in stress-induced serum amyloid A synthesis
    Maria Konstandi, Ioannis Sotiropoulos, Tsutomu Matsubara, Foteini Malliou, Alexandra E Katsogridaki, Christina E. Andriopoulou, Frank J. Gonzalez · 2019 · Psychopharmacology
  28. Suppression of Mouse AApoAII Amyloidosis Progression by Daily Supplementation with Oxidative Stress Inhibitors
    Jian Dai, Xin Ding, Hiroki Miyahara, Zhe Xu, Xiaoran Cui, Yuichi Igarashi, Jinko Sawashita, Masayuki Mori, Keiichi Higuchi · 2019 · Oxidative Medicine and Cellular Longevity
  29. Morphological analysis of Apolipoprotein E binding to Aβ Amyloid using a combination of Surface Plasmon Resonance, Immunogold Labeling and Scanning Electron Microscopy
    Tohidul Islam, Anna L. Gharibyan, Cheng Choo Lee, Anders Olofsson · 2019 · BMC Biotechnology
  30. Ursachen und Behandlungskonzepte der Demenzen
    Hans Förstl, Hans J. Lauter, Horst Bickel · 2001 · VS Verlag für Sozialwissenschaften eBooks
  31. Serpin Acceleration of Amyloid Fibril Formation: A Role for Accessory Proteins
    Glenn A. Powers, Chi L.L. Pham, Mary C. Pearce, Geoffrey J. Howlett, Stephen Bottomley · 2006 · Journal of Molecular Biology
  32. Alpha-1-Antichymotrypsin Polymorphism in Schizophrenia: Frequency, Age at Onset and Cognitive Function
    Hsien-Jane Chiu, Chen‐Jee Hong, Jen-Yeu Chen, Ying‐Chieh Wang, Chih‐Yuan Lin, Ya‐Mei Bai, Hsiu‐Li Song, Hao‐Che Lai, Shih‐Jen Tsai · 1999 · Neuropsychobiology
  33. Cell Cycle and Chromosome Segregation Defects in Alzheimer’s Disease
    Huntington Potter · 2005 · Springer eBooks
  34. Prostaglandin E2 Induced Polymerization of Human α-1-Antichymotrypsin and Suppressed Its Protease Inhibitory Activity: Implications for Alzheimer's Disease
    Federico Licastro, Lizabeth Jane Davis, Steve Pedrini, Douglas R Galasko, E. Masliah · 1998 · Biochemical and Biophysical Research Communications
  35. Plug‐Based Microfluidics with Defined Surface Chemistry to Miniaturize and Control Aggregation of Amyloidogenic Peptides
    Matthias Meier, Julia Kennedy‐Darling, Se Hoon Choi, Eric M. Norstrom, Sangram S. Sisodia, Rustem F. Ismagilov · 2009 · Angewandte Chemie
  36. Reduced Autophagy in Aged Trigeminal Neurons Causes Amyloid β Diffusion
    R. Sonoda, E. Kuramoto, S. Minami, Shin‐ei Matsumoto, Yasumasa Ohyagi, Takashi Saito, TC Saido, Kazuyuki Noguchi, Tetsuya Goto · 2023 · Journal of Dental Research
  37. Novel immunological approaches for the treatment of Alzheimer's disease.
    Priyanka Sabharwal, Thomas Wısnıewskı · 2014 · PubMed
  38. Therapeutic strategies against protein misfolding in neurodegenerative diseases
    Claudio A. Soto, Zane S. Martin · 2008 · Expert Opinion on Drug Discovery
  39. Role of apoE in conformation-prone diseases and atherosclerosis
    Alexander D. Dergunov · 2006 · Biochemistry (Moscow)
  40. Brownian dynamics simulation of insulin microsphere formation from break-up of a fractal network
    Wei Li, J. D. Gunton, Siddique J. Khan, J. K. Schoelz, A. Chakrabarti · 2011 · The Journal of Chemical Physics
  41. Similar promotion of Aβ1-42 fibrillogenesis by native apolipoprotein E ε3 and ε4 isoforms
    David A. Sweeney, Ralph Nigel Martins, Harry LeVine, Jonathan D. Smith, Sam Gandy · 2004 · Journal of Neuroinflammation
  42. Very Low Density Lipoprotein Receptor and Alzheimer’s Disease
    K. Ikeda, Takako Aizawa, Seichi Haga, N. Otsuka, Masashi Mizuguchi, Y Namba, Rikuo Machinami, S. U. Kim, Tokuo T. Yamamoto · 1996 · Springer eBooks
  43. Editorial Central & Peripheral Nervous Systems: Amyloid β Peptide in Alzheimer's Disease Pathology: Towards a Rational Basis for Drug Discovery?
    Michael J. Williams, Kazumi Shiosaki, Pamela S. Puttfarcken · 1995 · Expert Opinion on Investigational Drugs
  44. Inhibition of α2-macroglobulin/proteinase-mediated degradation of amyloid β peptide by apolipoprotein E and α1-antichymotrypsin; Evidence that the α2-macroglobulin/proteinase complex mediates degradation of the Aβ peptide
    Zhiyuan Zhang, Gary J. Drzewiecki, Patrick C. May, Russell E. Rydel, Steven M. Paul, Paul A. Hyslop · 1996 · Amyloid
  45. Non-Anticoagulant Actions of Glycosaminoglycans (GAGs)
    Umberto Cornelli · 1996 · Springer eBooks
  46. aGEM: an integrative system for analyzing spatial-temporal gene-expression information
    Natalia Jiménez-Lozano, Joan Segura, José Ramón Macías, Juanjo Vega, J.M. Carazo · 2009 · Bioinformatics
  47. Design of Inhibitors of Amyloid-β Misfolding and Aggregation for Alzheimer's Therapy
    Lisbell D. Estrada, Cristian A. Lasagna‐Reeves, Claudio A. Soto · 2007 · Springer eBooks
  48. The genetics of dementia with Lewy bodies
    Magdalena Ioana Tolea, James E. Galvin · 2018 · Handbook of clinical neurology
  49. The Impact of Apolipoprotein E Allelic Variants on Alzheimer’s Disease
    Ezequiel Serrano, Pablo G. Sanz, Francisco José Barrantes · 2021 · Springer eBooks
  50. Apolipoprotein E4 suppresses delayed-rectifier potassium channels in membrane patches excised from hippocampal neurons
    Ying Qin, Jin‐Shun Qi, Jian‐Tian Qiao · 2005 · Synapse
  51. The Defective Secretion of a Naturally Occurring α‐1‐Antichymotrypsin Variant with a Frameshift Mutation
    Michio Tsuda, Yukari Sei, Tomoichi Ohkubo, M. Yamamura, Hiroshi Kamiguchi, Akira Akatsuka, Toshio Tsuda, Hiroshi Tachikawa, Masahiro Yamamoto, Yukito Shinohara · 1996 · European Journal of Biochemistry
  52. Rate of cognitive decline in Alzheimer's disease is not affected by the alpha-1-antichymotrypsin A allele or the CYP2D6 B mutant
    Greer M. Murphy, Lan Yang, Jerome Albert Yesavage, Jared R. Tinklenberg · 1996 · Neuroscience Letters
  53. Reactive astrocytes transduce blood-brain barrier dysfunction through a TNFα-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin
    Hyosung Kim, Kun Leng, Jinhee Park, Alexander G. Sorets, Suil Kim, Alena Shostak, Sarah M. Sturgeon, Emma H. Neal, Douglas G. McMahon, Matthew Schrag et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  54. Neurobiology of Disorders with Lewy Bodies
    Lawrence A. Hansen, Eliezer Masliah · 2001 · Elsevier eBooks
  55. Targeting the accomplice to thwart the culprit: a new target for the prevention of amyloid deposition
    David Borchelt · 2018 · Journal of Clinical Investigation
  56. Peripheral Markers of Alzheimer’s
    Maire E. Percy, David F. Andrews, Huntington Potter · 2000 · Humana Press eBooks
  57. Strategies to delay the onset of Alzheimer’s disease
    M H Hüll, Bernd L. Fiebich, Klaus Lieb · 2000 · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions
  58. Acute-Phase Proteins and Additional Protective Systems
    Jürgen Arnhold · 2019 · Elsevier eBooks
  59. Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein
    Masayo Fujita, Gilbert J. Ho, Yoshiki Takamatsu, Ryoko Wada, Kazutaka Ikeda, Makoto Hashimoto · 2020 · International Journal of Molecular Sciences
  60. Apolipoproteins in Different Amyloidoses
    Marcin Sadowski, Thomas Wısnıewskı · 2007 · Springer eBooks
  61. Putative Links Between Some of the Key Pathological Features of the Alzheimer's Brain
    Rémi Quirion, Daniel S. Auld, Uwe Beffert, Judes Poirier, Satyabrata Kar · 1998 · Elsevier eBooks
  62. No association of α1-antichymotrypsin flanking region polymorphism and Alzheimer disease risk in early- and late-onset Alzheimer disease patients
    Meredyth P. Bass, Larry H. Yamaoka, William K. Scott, Perry C. Gaskell, Kathleen Anne Welsh-Bohmer, Allen D. Roses, Ann M. Saunders, Jonathan L. Haines, Margaret Ann Pericak‐Vance · 1998 · Neuroscience Letters
  63. Apolipoprotein E interacts with amyloid-β oligomers via positively cooperative multivalent binding
    Swagatha Ghosh, Timir Baran Sil, Sukanta Dolai, Kanchan Garai · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
    2000 · Pure Amsterdam UMC
  65. Therapeutic potential of mesenchymal stem cells on cholesterol homeostasis‐associated genes in AD ‐like rats
    Mehrnaz Karimi Darabi, Arash Rafeeinia, Seyedeh Pardis Pezeshki, Zahra Nazeri, Alireza Kheirollah, Maryam Cheraghzadeh · 2025 · The FASEB Journal
  66. PATHOPHYSIOLOGY OF ALZHEIMER'S DISEASE: EXPERIMENTAL AND GENETIC FINDINGS
    Esen Saka · 2010 · The Turkish Journal of Geriatrics
  67. Apolipoprotein E (APOE) Isoforms and Neurobiology of Sporadic Alzheimer’s Disease
    Anita Mollica, Giuseppe Berardino, Antonello Bellomo, Mario Altamura, Francesco Panza, Madia Lozupone · 2024 · Springer eBooks
  68. Связь матричных процессов I и II рода: амилоиды и стабильность генома
    Yu. V. Andreychuk, Sergey P. Zadorsky, Anna S. Zhuk, Elena Igorevna Stepchenkova, Sergey Georgievich Inge-Vechtomov · 2020 · Molecular Biology
  69. The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview
    Laura Morelli, George L. Perry, Fabrizio Tagliavini · 2012 · International Journal of Alzheimer s Disease
  70. P3‐419: GM‐CSF up‐regulated in reumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice
    Timothy D. Boyd · 2010 · Alzheimer s & Dementia
  71. Cellular and molecular mechanisms of Alzheimer’s disease inflammation
    Harry E. Peery, Ron Strohmeyer, Joseph Rogers · 2001 · Birkhäuser Basel eBooks
  72. Alzheimer’s Disease
    Joshua H. K. Tam, Stephen Pasternak · 2017 · Elsevier eBooks
  73. Extracellular Chaperones
    Rebecca A. Dabbs, Amy R. Wyatt, Justin J. Yerbury, Heath W. Ecroyd, Mark R. Wilson · 2010 · Topics in current chemistry
  74. Chapter 4. Emerging Opportunities in Neuroinflammatory Mechanisms of Neurodegeneration
    Kazumi Shiosaki, Pamela S. Puttfarcken · 1995 · Annual reports in medicinal chemistry
  75. Amyloid Precursor Protein
    C. C. F. Blake · 2002 · Encyclopedia of Molecular Biology
  76. Is there an association of regulatory region polymorphism in the alpha-1-antichymotrypsin gene with sporadic Alzheimer’s disease in the northern Han-Chinese population?
    Guran Yu, Jianping Jia · 2010 · Journal of Clinical Neuroscience
  77. Genetik der Alzheimer Demenz
    Reinhard Heun, Andreas Papassotiropoulos · 1999 · Springer eBooks
  78. Absence of the A1252G Mutation in α 1-Antichymotrypsin in a North American Population Suffering from Dementia
    Brian Mark Gilfix, Luis Briones · 1997 · Journal of Cerebral Blood Flow & Metabolism
  79. Signaling by β-Amyloid Precursor Protein
    Katsutoshi Furukawa · 1998 · Humana Press eBooks
  80. Integrated Network-Based Analysis of Diseases Associated with Amyloid Deposition Through a Disease–Protein–Drug Network
    Aikaterini E. I. Rizou, Georgia I. Nasi, Avgi E. Apostolakou, Meletios Athanasios Dimopoulos, Efstathios Kastritis, Vassiliki A. Iconomidou · 2024 · Pharmaceuticals
  81. Protective mutations associated with APOE in Alzheimer’s disease
    Yuejia Ma, Yanxi Li, Guangrun Wu, Lulu Liu, Mengjie Tian, Xinyu Han, Xinyi Chen, Xiuchen Xuan, Tianhu Zheng, Xu Gao et al. · 2026 · Molecular Psychiatry
  82. Role of Apolipoprotein E in Alzheimer’s Disease: Clues from its Structure
    Karl Heinrich Weisgraber, Li Dong · 1996 · Springer eBooks
  83. Revisiting the genetics of APOE
    Susana Carmona, Célia Kun‐Rodrigues, José Brás, Rita João Guerreiro · 2017 · UCL Discovery (University College London)
  84. Genetics, Alzheimer’s disease and Down syndrome
    Nicole Schupf · 2018 · CRC Press eBooks
  85. The Metabolism of Apolipoprotein E and the Alzheimer's Diseases
    Allen D. Roses · 1996 · Informa Healthcare eBooks
  86. Relationship between Type I and Type II Template Processes: Amyloids and Genome Stability
    Yu. V. Andreychuk, Sergey P. Zadorsky, Anna S. Zhuk, Elena Igorevna Stepchenkova, Sergey Georgievich Inge-Vechtomov · 2020 · Molecular Biology
  87. The Molecular Mechanism of Amyloidosis in Alzheimer’s Disease
    Michael G. Zagorski · 1999 · CRC Press eBooks
  88. HB-GAM, a Novel Amyloid Associated Protein, is Present in Prion Related Disorders and other Cerebral Amyloidoses
    Maciej M. Lalowski, Marc Baumann, Heikki Rauvala, Blas Frangione, Thomas Wısnıewskı · 1998 · Advances in behavioral biology
  89. Alzheimer�s Disease, Molecular Biology and the Future of Rational Neuropsychotropic Drug Development
    Joseph T. Coyle · 1998 · KARGER eBooks
  90. Potential Biological Mechanisms of ApoE in Alzheimer’s Disease
    George William Rebeck · 1997 · Humana Press eBooks
  91. Apolipoprotein E and inclusion body myositis
    Michael J. Garlepp, Frank Louis Mastaglia · 1996 · Annals of Neurology
  92. Chaperoning Amyloid in Alzheimer’s Disease: The Art of Avoiding Sticky Situations?
    Blas Frangione, Eduardo Miguel Castaño, Frances Prelli, Claudio A. Soto, Jorge A. Ghiso, Thomas Wısnıewskı · 1996 · Springer eBooks
  93. [Inflammatory mechanisms in the pathogenesis of Alzheimer's disease].
    Marcel M. Verbeek, Irene Otte‐Höller, D.J. Ruiter, Robert M.W. de Waal · 1997 · PubMed
  94. Apolipoprotein E: Structural and Functional Interactions with Amyloid β
    W. Blaine Stine, Mary Jo LaDu · 2005 · Wiley eBooks
  95. Genetically Engineered Models of Human Age-Related Neurodegenerative Diseases
    James Clement Vickers · 2001 · Elsevier eBooks
  96. Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition
    Noah R. Johnson, Athena C.-J. Wang, Christina M. Coughlan, Stefan Sillau, Esteban Lucero, Lisa Viltz, Neil E. Markham, Cody Allen, A. Ranjitha Dhanasekaran, Heidi J. Chial et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Differential Regulation of APP Secretion by Apolipoprotein E3 and E4
    Benjamin L. Wolozin, Jasna Basaric-Keys, Robert J. Canter, Yunhua Li, Dudley K. Strickland, Trey Sunderland · 1996 · Springer eBooks
  98. Activated Neuroglia in Alzheimer's Disease
    Kurt R. Brunden, Robert C.A. Frederickson · 2002 · Humana Press eBooks
  99. New insights into the structural basis of 1,-antitrypsin deficiency
    David A. Lomas · 1996 · QJM
  100. The Vascular Dementias and Cerebrovascular Involvement in Alzheimer’s Disease
    J. G. Schulz, K. M. Einhäupl · 1996 · Springer eBooks